COMMENTARY: BRCA1/2 Mutations, Vulnerability to Breast/Ovarian Cancer, and Current and Future Treatment Modalities. J. Can. Res. Updates [Internet]. 2016 Mar. 29 [cited 2026 Apr. 22];5(2): 45-46. Available from: https://www.neoplasiaresearch.com/index.php/jcru/article/view/435